Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effectiveness and safety of mononuclear cell therapy in chronic limb ischemia
TCTR20220502003Phase 3Recruiting
- Sponsor
- Mahidol University
- Start
- May 2022
- Countries
- 1
01
Overview
Phase 3 trial in chronic limb-threatening ischaemia (CLTI), sponsored by Mahidol University. Started May 2022; status: recruiting.
02
Conditions
chronic limb-threatening ischaemia (CLTI)
Beyond the preview
Go deeper on TCTR20220502003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20220502003.